<DOC>
	<DOCNO>NCT02052921</DOCNO>
	<brief_summary>With possibility pathological complete response surgical specimen , author propose non-operative management patient group , re-staged neoadjuvant treatment , complete clinical response . So far , approach remains discussed literature , still many uncertainty patient clinical complete response chemoradiotherapy fact detectable viable tumor may omit radical surgical treatment . It still investigational approach actually gain space even patient high refuse surgery clarification surgical risk . Hypothesis : The preservation rectum patient adenocarcinoma middle distal rectum ( 10 cm ) reach clinical complete response neoadjuvant chemoradiotherapy similar rate rectal cancer recurrence patient underwent surgical rectal resection . This prospective , randomize , open label phase II surgical resection versus conservative treatment ( observation ) patient mid distal rectal cancer achieve complete neoadjuvant chemoradiotherapy combine clinical response . The main objective study ass whether conservative approach similar rectosigmoidectomy complete mesorectal excision amputation abdminoperineal rectum patient complete clinical response neoadjuvant therapy combine chemoradiotherapy . Patient Selection : To eligible patient neoadjuvant prior histologic diagnosis rectal adenocarcinoma , tumor locate within 10 cm anal verge , complete clinical response treatment chemoradiotherapy rectal tumor stag clinical radiological T3-4 N0 M0 T ( ) N + M0 , absence colorectal synchronous tumor . Treatment : Eligible patient randomize 1:1 resection rectum notice . The period randomization patient 12 week last dose radiotherapy / chemotherapy , properly assess antitumor response describe . After randomization , patient surgical group undergo resection rectum complete excision mesorectal within 2 week randomization .</brief_summary>
	<brief_title>Observation Versus Surgical Resection Patients With Rectal Cancer Who Achieved Complete Clinical Response After Neoadjuvant Chemoradiotherapy</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Histological diagnosis rectal adenocarcinoma tumor locate within 10 cm anal verge rigid proctoscopy measurement Complete clinical response neoadjuvant treatment chemoradiotherapy rectal tumor clinical radiologically stag T34 N0 M0 T ( ) N + M0 Absence colorectal synchronous tumor Age 18 75 year ECOG performance scale â‰¤ 2 , last dose chemotherapy / radiation therapy 12 week Good organic function Absence serious comorbidities define doctor prevent surgical resection rectum / neoadjuvant therapy . Comorbidities clinically significant surgical resection / neoadjuvant therapy impossible , accord medical assessment . Prior antineoplastic therapy different neoadjuvant therapy . History Crohn 's disease ulcerative colitis . Confirmation strongly suspect inherited polyp syndrome . Pregnant woman lactation ( woman childbearing age negative pregnancy test ) . Concurrent participation another research protocol involve therapeutic intervention .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Observation</keyword>
	<keyword>Rectal Resection</keyword>
	<keyword>complete clinical response</keyword>
	<keyword>neoadjuvant chemoradiotherapy .</keyword>
</DOC>